|
J Biol Chem, Vol. 274, Issue 28, 19707-19713, July 9, 1999
Regulation of Glycosphingolipid Metabolism in Liver during the
Acute Phase Response
Riaz A.
Memon,
Walter M.
Holleran,
Yoshikazu
Uchida,
Arthur H.
Moser,
Shinichi
Ichikawa ,
Yoshio
Hirabayashi ,
Carl
Grunfeld, and
Kenneth R.
Feingold
From the Departments of Medicine and Dermatology, University of
California San Francisco, Metabolism Section, Medical Service and
Dermatology Service, Department of Veterans Affairs Medical Center, San
Francisco, California 94121 and the Laboratory of
Cellular Glycobiology, Frontier Research Program, The Institute of
Physical and Chemical Research (RIKEN), 2-1 Hirosawa, Saitama
351-0198, Japan
The host response to infection is associated with
multiple alterations in lipid and lipoprotein metabolism. We have shown recently that endotoxin (lipopolysaccharide (LPS)) and cytokines enhance hepatic sphingolipid synthesis, increase the activity and
mRNA levels of serine palmitoyltransferase, the first committed step in sphingolipid synthesis, and increase the content of
sphingomyelin, ceramide, and glucosylceramide (GlcCer) in circulating
lipoproteins in Syrian hamsters. Since the LPS-induced increase in
GlcCer content of lipoproteins was far greater than that of ceramide or
sphingomyelin, we have now examined the effect of LPS and cytokines on
glycosphingolipid metabolism. LPS markedly increased the mRNA level
of hepatic GlcCer synthase, the enzyme that catalyzes the first
glycosylation step of glycosphingolipid synthesis. The LPS-induced
increase in GlcCer synthase mRNA levels was seen within 2 h,
sustained for 8 h, and declined to base line by 24 h.
LPS-induced increase in GlcCer synthase mRNA was partly accounted
for by an increase in its transcription rate. LPS produced a 3-4-fold
increase in hepatic GlcCer synthase activity and significantly
increased the content of GlcCer (the immediate product of GlcCer
synthase reaction) as well as ceramide trihexoside and ganglioside GM3
(products distal to the GlcCer synthase step) in the liver. Moreover,
both tumor necrosis factor- and interleukin-1 , cytokines that
mediate many of the metabolic effects of LPS, increased hepatic GlcCer
synthase mRNA levels in vivo as well as in HepG2 cells
in vitro, suggesting that these cytokines can directly
stimulate glycosphingolipid metabolism. These results indicate that LPS
and cytokines up-regulate glycosphingolipid metabolism in
vivo and in vitro. An increase in GlcCer synthase mRNA levels and activity leads to the increase in hepatic GlcCer content and may account for the increased GlcCer content in circulating lipoproteins during the acute phase response.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. V. Giltiay, A. A. Karakashian, A. P. Alimov, S. Ligthle, and M. N. Nikolova-Karakashian
Ceramide- and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1{beta} in hepatocytes
J. Lipid Res.,
November 1, 2005;
46(11):
2497 - 2505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kohyama-Koganeya, T. Sasamura, E. Oshima, E. Suzuki, S. Nishihara, R. Ueda, and Y. Hirabayashi
Drosophila Glucosylceramide Synthase: A NEGATIVE REGULATOR OF CELL DEATH MEDIATED BY PROAPOPTOTIC FACTORS
J. Biol. Chem.,
August 20, 2004;
279(34):
35995 - 36002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
J. Lipid Res.,
July 1, 2004;
45(7):
1169 - 1196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Yoo and S. Desiderio
Innate and acquired immunity intersect in a global view of the acute-phase response
PNAS,
February 4, 2003;
100(3):
1157 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Uchida, S. Murata, M. Schmuth, M. J. Behne, J. D. Lee, S. Ichikawa, P. M. Elias, Y. Hirabayashi, and W. M. Holleran
Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress
J. Lipid Res.,
August 1, 2002;
43(8):
1293 - 1302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Khovidhunkit, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold
Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines
J. Lipid Res.,
October 1, 2001;
42(10):
1636 - 1644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Memon, W. M. Holleran, Y. Uchida, A. H. Moser, C. Grunfeld, and K. R. Feingold
Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin
J. Lipid Res.,
March 1, 2001;
42(3):
452 - 459.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. A. Boldin and A. H. Futerman
Up-regulation of Glucosylceramide Synthesis upon Stimulation of Axonal Growth by Basic Fibroblast Growth Factor. EVIDENCE FOR POST-TRANSLATIONAL MODIFICATION OF GLUCOSYLCERAMIDE SYNTHASE
J. Biol. Chem.,
March 31, 2000;
275(14):
9905 - 9909.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|